Edition:
United Kingdom

GenMark Diagnostics Inc (GNMK.OQ)

GNMK.OQ on NASDAQ Stock Exchange Global Market

6.75USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$6.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
87,436
52-wk High
$12.55
52-wk Low
$3.63

Latest Key Developments (Source: Significant Developments)

Genmark Diagnostics Announces FDA Submission Of Its ePlex Blood Culture Identification Gram Positive Panel
Thursday, 28 Jun 2018 

June 28 (Reuters) - GenMark Diagnostics Inc ::GENMARK DIAGNOSTICS ANNOUNCES FDA SUBMISSION OF ITS EPLEX BLOOD CULTURE IDENTIFICATION GRAM POSITIVE PANEL.GENMARK DIAGNOSTICS INC - ANTICIPATES FDA SUBMISSION OF GRAM NEGATIVE PANEL (BCID-GN) AND FUNGAL PATHOGEN PANEL (BCID-FP) IN Q3 AND Q4 THIS YEAR.  Full Article

GenMark Diagnostics Sees Q4 2017 Revenue About $16 Mln
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Genmark Diagnostics Inc ::GENMARK DIAGNOSTICS PROVIDES PRELIMINARY OPERATIONAL AND FINANCIAL RESULTS FOR 2017.SEES FY 2017 REVENUE ABOUT $52.5 MILLION.SEES Q4 2017 REVENUE ABOUT $16 MILLION.SEES FY 2017 REVENUE UP 7 PERCENT.SEES Q4 2017 REVENUE UP 8 PERCENT.Q4 REVENUE VIEW $15.2 MILLION -- THOMSON REUTERS I/B/E/S.FY2017 REVENUE VIEW $51.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Genmark Diagnostics Entered Fifth Amendment To Loan And Security Agreement
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Genmark Diagnostics Inc ::GENMARK DIAGNOSTICS INC - ON DEC 13 CO ENTERED FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT WITH SOLAR SENIOR CAPITAL - SEC FILING.GENMARK DIAGNOSTICS INC - AS PER AMENDMENT, MATURITY DATE FOR LOAN AND SECURITY AGREEMENT EXTENDED TO MARCH 12, 2020.  Full Article

Genmark Diagnostics Q3 loss per share $0.28
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Genmark Diagnostics Inc :Genmark diagnostics reports third quarter 2017 results.Q3 loss per share $0.28.Q3 revenue rose 7.3 percent to $11.6 million.Q3 revenue view $14.6 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue $51 million to $53 million.  Full Article

Morgan Stanley reports 5 pct passive stake in GenMark Diagnostics as of Aug 17
Monday, 29 Aug 2016 

GenMark Diagnostics Inc :Morgan Stanley reports 5.0 percent passive stake in GenMark Diagnostics Inc as of August 17 -Sec filing.  Full Article